Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2021 Earnings and Company Updates
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present its first quarter 2021 financial results and operational highlights in a conference call on May 6 at 8 a.m. E.T.
To join the call:
A replay of the call will be available through the Events and Presentations page of the Investors & Media section of the company’s website at www.intelliatx.com, beginning on May 6 at 12 p.m. E.T.
About Intellia Therapeutics
Networking LIVE! Reception - On the Amazing Spacious Seaside Patio of the Loews Miami Beach Resort
Business Continuity Solutions for the Modern Business
How SASE is Your Security Strategy?